Ken Griffin Sensus Healthcare, Inc. Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Sensus Healthcare, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 2,100 shares of SRTS stock, worth $17,703. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,100
Previous 600
250.0%
Holding current value
$17,703
Previous $3,000
300.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding SRTS
# of Institutions
59Shares Held
3.94MCall Options Held
24.9KPut Options Held
800-
Vanguard Group Inc Valley Forge, PA779KShares$6.57 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny409KShares$3.45 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA304KShares$2.56 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX290KShares$2.44 Million0.0% of portfolio
-
Morgan Stanley New York, NY185KShares$1.56 Million0.0% of portfolio
About Sensus Healthcare, Inc.
- Ticker SRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,556,000
- Market Cap $140M
- Description
- Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provide...